drugset / Trial / NCT00304863

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

NCT00304863

RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether dietary supplementation with Lactobacillus GG will reduce the rate of failure or relapse following treatment of CDAD with metronidazole.

Timeline

Start
2008-08-01
Primary completion
2010-07-31
Completion
2010-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus GG Other / unclassified